IBDEI0XS ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,33984,2)
 ;;=^5003959
 ;;^UTILITY(U,$J,358.3,33985,0)
 ;;=I69.920^^122^1603^5
 ;;^UTILITY(U,$J,358.3,33985,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33985,1,3,0)
 ;;=3^Late Eff of Stroke,Aphasia
 ;;^UTILITY(U,$J,358.3,33985,1,4,0)
 ;;=4^I69.920
 ;;^UTILITY(U,$J,358.3,33985,2)
 ;;=^5007553
 ;;^UTILITY(U,$J,358.3,33986,0)
 ;;=I69.921^^122^1603^8
 ;;^UTILITY(U,$J,358.3,33986,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33986,1,3,0)
 ;;=3^Late Eff of Stroke,Dysphasia
 ;;^UTILITY(U,$J,358.3,33986,1,4,0)
 ;;=4^I69.921
 ;;^UTILITY(U,$J,358.3,33986,2)
 ;;=^5007554
 ;;^UTILITY(U,$J,358.3,33987,0)
 ;;=I69.922^^122^1603^6
 ;;^UTILITY(U,$J,358.3,33987,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33987,1,3,0)
 ;;=3^Late Eff of Stroke,Dysarthria
 ;;^UTILITY(U,$J,358.3,33987,1,4,0)
 ;;=4^I69.922
 ;;^UTILITY(U,$J,358.3,33987,2)
 ;;=^5007555
 ;;^UTILITY(U,$J,358.3,33988,0)
 ;;=I69.959^^122^1603^9
 ;;^UTILITY(U,$J,358.3,33988,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33988,1,3,0)
 ;;=3^Late Eff of Stroke,Hemiplegia
 ;;^UTILITY(U,$J,358.3,33988,1,4,0)
 ;;=4^I69.959
 ;;^UTILITY(U,$J,358.3,33988,2)
 ;;=^5007563
 ;;^UTILITY(U,$J,358.3,33989,0)
 ;;=I69.991^^122^1603^7
 ;;^UTILITY(U,$J,358.3,33989,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33989,1,3,0)
 ;;=3^Late Eff of Stroke,Dysphagia
 ;;^UTILITY(U,$J,358.3,33989,1,4,0)
 ;;=4^I69.991
 ;;^UTILITY(U,$J,358.3,33989,2)
 ;;=^5007569
 ;;^UTILITY(U,$J,358.3,33990,0)
 ;;=R41.3^^122^1603^10
 ;;^UTILITY(U,$J,358.3,33990,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33990,1,3,0)
 ;;=3^Memory Loss
 ;;^UTILITY(U,$J,358.3,33990,1,4,0)
 ;;=4^R41.3
 ;;^UTILITY(U,$J,358.3,33990,2)
 ;;=^5019439
 ;;^UTILITY(U,$J,358.3,33991,0)
 ;;=S06.9X9S^^122^1603^2
 ;;^UTILITY(U,$J,358.3,33991,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33991,1,3,0)
 ;;=3^Brain Injury w/ LOC,Sequela
 ;;^UTILITY(U,$J,358.3,33991,1,4,0)
 ;;=4^S06.9X9S
 ;;^UTILITY(U,$J,358.3,33991,2)
 ;;=^5021235
 ;;^UTILITY(U,$J,358.3,33992,0)
 ;;=Z95.1^^122^1603^3
 ;;^UTILITY(U,$J,358.3,33992,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33992,1,3,0)
 ;;=3^CABG,Status Post
 ;;^UTILITY(U,$J,358.3,33992,1,4,0)
 ;;=4^Z95.1
 ;;^UTILITY(U,$J,358.3,33992,2)
 ;;=^5063669
 ;;^UTILITY(U,$J,358.3,33993,0)
 ;;=I73.9^^122^1604^7
 ;;^UTILITY(U,$J,358.3,33993,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33993,1,3,0)
 ;;=3^PVD,Unspec
 ;;^UTILITY(U,$J,358.3,33993,1,4,0)
 ;;=4^I73.9
 ;;^UTILITY(U,$J,358.3,33993,2)
 ;;=^184182
 ;;^UTILITY(U,$J,358.3,33994,0)
 ;;=I83.91^^122^1604^10
 ;;^UTILITY(U,$J,358.3,33994,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33994,1,3,0)
 ;;=3^Varicose Veins,Right Lower Extremity
 ;;^UTILITY(U,$J,358.3,33994,1,4,0)
 ;;=4^I83.91
 ;;^UTILITY(U,$J,358.3,33994,2)
 ;;=^5008020
 ;;^UTILITY(U,$J,358.3,33995,0)
 ;;=I83.92^^122^1604^9
 ;;^UTILITY(U,$J,358.3,33995,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33995,1,3,0)
 ;;=3^Varicose Veins,Left Lower Extremity
 ;;^UTILITY(U,$J,358.3,33995,1,4,0)
 ;;=4^I83.92
 ;;^UTILITY(U,$J,358.3,33995,2)
 ;;=^5008021
 ;;^UTILITY(U,$J,358.3,33996,0)
 ;;=I89.0^^122^1604^5
 ;;^UTILITY(U,$J,358.3,33996,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33996,1,3,0)
 ;;=3^Lymphedema NEC
 ;;^UTILITY(U,$J,358.3,33996,1,4,0)
 ;;=4^I89.0
 ;;^UTILITY(U,$J,358.3,33996,2)
 ;;=^5008073
 ;;^UTILITY(U,$J,358.3,33997,0)
 ;;=I87.2^^122^1604^11
 ;;^UTILITY(U,$J,358.3,33997,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33997,1,3,0)
 ;;=3^Venous Insufficiency
 ;;^UTILITY(U,$J,358.3,33997,1,4,0)
 ;;=4^I87.2
 ;;^UTILITY(U,$J,358.3,33997,2)
 ;;=^5008047
 ;;^UTILITY(U,$J,358.3,33998,0)
 ;;=L98.499^^122^1604^6
 ;;^UTILITY(U,$J,358.3,33998,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33998,1,3,0)
 ;;=3^Non-Pressure Ulcer of Skin
 ;;^UTILITY(U,$J,358.3,33998,1,4,0)
 ;;=4^L98.499
 ;;^UTILITY(U,$J,358.3,33998,2)
 ;;=^5009591
 ;;^UTILITY(U,$J,358.3,33999,0)
 ;;=M32.10^^122^1604^8
 ;;^UTILITY(U,$J,358.3,33999,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33999,1,3,0)
 ;;=3^Systemic Lupus Erythematosus
 ;;^UTILITY(U,$J,358.3,33999,1,4,0)
 ;;=4^M32.10
 ;;^UTILITY(U,$J,358.3,33999,2)
 ;;=^5011753
 ;;^UTILITY(U,$J,358.3,34000,0)
 ;;=R60.0^^122^1604^2
 ;;^UTILITY(U,$J,358.3,34000,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34000,1,3,0)
 ;;=3^Edema,Localized
 ;;^UTILITY(U,$J,358.3,34000,1,4,0)
 ;;=4^R60.0
 ;;^UTILITY(U,$J,358.3,34000,2)
 ;;=^5019532
 ;;^UTILITY(U,$J,358.3,34001,0)
 ;;=R60.1^^122^1604^1
 ;;^UTILITY(U,$J,358.3,34001,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34001,1,3,0)
 ;;=3^Edema,Generalized
 ;;^UTILITY(U,$J,358.3,34001,1,4,0)
 ;;=4^R60.1
 ;;^UTILITY(U,$J,358.3,34001,2)
 ;;=^5019533
 ;;^UTILITY(U,$J,358.3,34002,0)
 ;;=R60.9^^122^1604^3
 ;;^UTILITY(U,$J,358.3,34002,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34002,1,3,0)
 ;;=3^Edema,Unspec
 ;;^UTILITY(U,$J,358.3,34002,1,4,0)
 ;;=4^R60.9
 ;;^UTILITY(U,$J,358.3,34002,2)
 ;;=^5019534
 ;;^UTILITY(U,$J,358.3,34003,0)
 ;;=I96.^^122^1604^4
 ;;^UTILITY(U,$J,358.3,34003,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34003,1,3,0)
 ;;=3^Gangrene NEC
 ;;^UTILITY(U,$J,358.3,34003,1,4,0)
 ;;=4^I96.
 ;;^UTILITY(U,$J,358.3,34003,2)
 ;;=^5008081
 ;;^UTILITY(U,$J,358.3,34004,0)
 ;;=E10.9^^122^1605^5
 ;;^UTILITY(U,$J,358.3,34004,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34004,1,3,0)
 ;;=3^DM Type 1 w/o Complications
 ;;^UTILITY(U,$J,358.3,34004,1,4,0)
 ;;=4^E10.9
 ;;^UTILITY(U,$J,358.3,34004,2)
 ;;=^5002626
 ;;^UTILITY(U,$J,358.3,34005,0)
 ;;=E11.40^^122^1605^7
 ;;^UTILITY(U,$J,358.3,34005,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34005,1,3,0)
 ;;=3^DM Type 2 w/ Neuropathy Manifestations
 ;;^UTILITY(U,$J,358.3,34005,1,4,0)
 ;;=4^E11.40
 ;;^UTILITY(U,$J,358.3,34005,2)
 ;;=^5002644
 ;;^UTILITY(U,$J,358.3,34006,0)
 ;;=E10.40^^122^1605^2
 ;;^UTILITY(U,$J,358.3,34006,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34006,1,3,0)
 ;;=3^DM Type 1 w/ Neuropathy Manifestations
 ;;^UTILITY(U,$J,358.3,34006,1,4,0)
 ;;=4^E10.40
 ;;^UTILITY(U,$J,358.3,34006,2)
 ;;=^5002604
 ;;^UTILITY(U,$J,358.3,34007,0)
 ;;=E11.51^^122^1605^9
 ;;^UTILITY(U,$J,358.3,34007,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34007,1,3,0)
 ;;=3^DM Type 2 w/ Peripheral Circulatory Disease
 ;;^UTILITY(U,$J,358.3,34007,1,4,0)
 ;;=4^E11.51
 ;;^UTILITY(U,$J,358.3,34007,2)
 ;;=^5002650
 ;;^UTILITY(U,$J,358.3,34008,0)
 ;;=E10.51^^122^1605^4
 ;;^UTILITY(U,$J,358.3,34008,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34008,1,3,0)
 ;;=3^DM Type 1 w/ Peripheral Circulatory Disease
 ;;^UTILITY(U,$J,358.3,34008,1,4,0)
 ;;=4^E10.51
 ;;^UTILITY(U,$J,358.3,34008,2)
 ;;=^5002610
 ;;^UTILITY(U,$J,358.3,34009,0)
 ;;=E11.621^^122^1605^6
 ;;^UTILITY(U,$J,358.3,34009,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34009,1,3,0)
 ;;=3^DM Type 2 w/ Foot Ulcer
 ;;^UTILITY(U,$J,358.3,34009,1,4,0)
 ;;=4^E11.621
 ;;^UTILITY(U,$J,358.3,34009,2)
 ;;=^5002656
 ;;^UTILITY(U,$J,358.3,34010,0)
 ;;=E10.621^^122^1605^1
 ;;^UTILITY(U,$J,358.3,34010,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34010,1,3,0)
 ;;=3^DM Type 1 w/ Foot Ulcer
 ;;^UTILITY(U,$J,358.3,34010,1,4,0)
 ;;=4^E10.621
 ;;^UTILITY(U,$J,358.3,34010,2)
 ;;=^5002616
 ;;^UTILITY(U,$J,358.3,34011,0)
 ;;=E11.51^^122^1605^8
 ;;^UTILITY(U,$J,358.3,34011,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34011,1,3,0)
 ;;=3^DM Type 2 w/ Peripheral Angiopathy
 ;;^UTILITY(U,$J,358.3,34011,1,4,0)
 ;;=4^E11.51
 ;;^UTILITY(U,$J,358.3,34011,2)
 ;;=^5002650
 ;;^UTILITY(U,$J,358.3,34012,0)
 ;;=E10.51^^122^1605^3
 ;;^UTILITY(U,$J,358.3,34012,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34012,1,3,0)
 ;;=3^DM Type 1 w/ Peripheral Angiopathy
 ;;^UTILITY(U,$J,358.3,34012,1,4,0)
 ;;=4^E10.51
 ;;^UTILITY(U,$J,358.3,34012,2)
 ;;=^5002610
 ;;^UTILITY(U,$J,358.3,34013,0)
 ;;=S43.001S^^122^1606^20
 ;;^UTILITY(U,$J,358.3,34013,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34013,1,3,0)
 ;;=3^Subluxation,Right Shoulder,Sequela
